These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28628706)

  • 21. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria.
    Cubiella J; Salve M; Díaz-Ondina M; Vega P; Alves MT; Iglesias F; Sánchez E; Macía P; Blanco I; Bujanda L; Fernández-Seara J
    Colorectal Dis; 2014 Aug; 16(8):O273-82. PubMed ID: 24456168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.
    Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J;
    BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
    Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
    Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG;
    Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population.
    Stonestreet J; Chandrapalan S; Woolley D; Uthman U; Arasaradnam RP
    Acta Gastroenterol Belg; 2019; 82(2):291-299. PubMed ID: 31314191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
    Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
    Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal immunochemical test accuracy in average-risk colorectal cancer screening.
    Hernandez V; Cubiella J; Gonzalez-Mao MC; Iglesias F; Rivera C; Iglesias MB; Cid L; Castro I; de Castro L; Vega P; Hermo JA; Macenlle R; Martínez-Turnes A; Martínez-Ares D; Estevez P; Cid E; Vidal MC; López-Martínez A; Hijona E; Herreros-Villanueva M; Bujanda L; Rodriguez-Prada JI;
    World J Gastroenterol; 2014 Jan; 20(4):1038-47. PubMed ID: 24574776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?
    Kim NH; Yang HJ; Park SK; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Dig Dis Sci; 2016 Sep; 61(9):2685-93. PubMed ID: 27107865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy Study.
    de Klaver W; Wisse PHA; van Wifferen F; Bosch LJW; Jimenez CR; van der Hulst RWM; Fijneman RJA; Kuipers EJ; Greuter MJE; Carvalho B; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    Ann Intern Med; 2021 Sep; 174(9):1224-1231. PubMed ID: 34280333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
    Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
    Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients.
    Rodriguez-Alonso L; Rodriguez-Moranta F; Arajol C; Gilabert P; Serra K; Martin A; Ibáñez-Sanz G; Moreno V; Guardiola J
    PLoS One; 2018; 13(8):e0203359. PubMed ID: 30169524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
    Larsen MB; Njor S; Ingeholm P; Andersen B
    Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal Immunochemical Testing in Patients With Low-Risk Symptoms of Colorectal Cancer: A Diagnostic Accuracy Study.
    Ball AJ; Aziz I; Parker S; Sargur RB; Aldis J; Kurien M
    J Natl Compr Canc Netw; 2022 Sep; 20(9):989-996.e1. PubMed ID: 36075395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis.
    Niedermaier T; Balavarca Y; Brenner H
    Am J Gastroenterol; 2020 Jan; 115(1):56-69. PubMed ID: 31850933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of Fecal Immunochemical Test for Colorectal Cancer Detection Differs According to Stage and Location.
    Niedermaier T; Tikk K; Gies A; Bieck S; Brenner H
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2920-2928.e6. PubMed ID: 31988043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies.
    Hirai HW; Tsoi KK; Chan JY; Wong SH; Ching JY; Wong MC; Wu JC; Chan FK; Sung JJ; Ng SC
    Aliment Pharmacol Ther; 2016 Apr; 43(7):755-64. PubMed ID: 26858128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Faecal immunochemical tests for the diagnosis of symptomatic colorectal cancer in primary care: the benefit of more than one sample.
    Högberg C; Söderström L; Lilja M
    Scand J Prim Health Care; 2017 Dec; 35(4):369-372. PubMed ID: 29183266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.